P/B
1,2
Innoviva
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
$1.4B
Market Cap • 11/6/2026
1996
(30 years)
Founded
2004
(22 years ago)
IPO
NASDAQ
Listing Exchange
United States
Country
Valuation
P/S
3,1
P/EBITDA
6,4
P/OCF
7,4
P/FCF
7,4
P/E
9,6
BVPS
16
EPS
2,5
Market Cap
Market Cap
1,4B
EV
1B
EV/Revenue
2,4
EV/EBITDA
4,9
EV/EBIT
6,1
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
5,8%
Total Yield
5,8%
Dividend Yield 5Y
0%
Payout
0%
Retained Earnings
298,7M
Profitability
Gross Margin
80,5%
EBITDA Margin
48,1%
EBIT Margin
38,8%
Net Margin
44,1%
D&A/EBITDA
12,6%
R&D/Revenue
4,6%
Capex/Revenue
0,2%
Capex/D&A
2,4%
Capex/OCF
0,5%
SBC/OCF
7,3%
% PPE
0,8%
% Goodwill
1,2%
ROE
18%
ROIC
18,8%
Growth
CAGR Revenue 5Y
3,2%
CAGR Op. Income 5Y
-13,7%
CAGR Net Income 5Y
-13,4%
CAGR EPS 5Y
-8,6%
CAGR OCF 5Y
-12,2%
Leverage
N.D./EBITDA
—
Debt/Equity
0%
Current Ratio
15,4
Quick Ratio
13,7
Interest Coverage
—
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!